“I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution,” Mr. Poonawalla added.
Adar Poonawalla, the CEO and owner of Serum Institute of India, asked whether the government of India will have Rs. 80,000 crore available by the next year. Mr. Poonawalla was referring to the tedious work of the procurement and distribution of the vaccine.
“Quick question; will the government of India have 80,000 crores available, over the next one year? Because that’s what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle,” Mr. Poonawalla said, tagging the handle of PMO on twitter.
“I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution,” he added.
I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution.
— Adar Poonawalla (@adarpoonawalla) September 26, 2020
India is eyeing the vaccine being prepared by Oxford-AstraZeneca of Britain and Moderna-NIAID of America. AstraZeneca is working closely with the Serum Institute of India (SII) to bring the vaccine to India.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
